Wegovy tablets (semaglutide pills)
Image 1 of 1: Wegovy tablets (semaglutide pills)
Prescription

Wegovy (semaglutide) tablets

Coming soon!

  • Consultations start from:TBC
Patient Information leaflet
  • Clinical studies in the US have shown Wegovy tablets may offer average weight loss of around 14%.
  • Wegovy tablets contain semaglutide, which helps reduce appetite and support weight loss.
  • In US trials Wegovy tablets worked best when used alongside lifestyle changes. 
  • Wegovy tablets are not yet available in the UK.
(4.5 stars)

Your weight loss journey, supported by our experts

Your online consultation

Request treatment

Start by checking your eligibility, then complete a fast, secure online consultation. A clinician reviews everything and, if you’re approved, your treatment plan begins.

The start of your journey

Ongoing support

You’ve started treatment, and you’re beginning to see results. You’re building healthier habits, feeling more confident, and noticing wins outside the scales. Think looser clothing and more energy for the things you love.

Long-term progress and maintenance

Expert reviews

You’ve settled into a routine that supports real, lasting change. The habits you’ve built now help keep the weight off for good, and our clinicians and weight loss specialists continue to guide you every step of the way.

BMI Calculator

Calculate your Body Mass Index to understand your weight category

120kg

165cm

Adjust the sliders and click Calculate BMI


Trusted, licensed and fully regulated

We're committed to your safety and wellbeing

We're fully licensed and regulated
  • How we're regulated

    All clincal assessments and medication prescribed is via myBMIs clinical team, including James O’Loan (GPhC: 2084549), Lou Humphreys (GPhC: 2049466) John Campbell (GPhC: 2069835) Ian Budd (GPhC: 2037876) Celina Mark (GPhC: 2216421) and Ayesha Bashir (GPhC: 2209645) who are all General Pharmaceutical Council (GPhC) registered, ensuring full compliance with professional requirements for GPhC prescribing. myBMI is also regulated via its partnership with its dispensing pharmacy Innox Trading Ltd, (t/a Chemist4U), which is registered with the GPhC under number 9012464.

FAQs

Need help?

It’s natural to have questions, and we’re here to keep things straightforward so you can stay focused on your journey.

Get support

What are Wegovy  tablets? 

Wegovy tablets are an oral semaglutide medication used to support weight loss by helping you regulate your appetite and food intake. They are designed for people who want medical support without injections. 

While Wegovy tablets have been approved in the US, they need to be approved by the Medicines and Healthcare products Regulatory Agency (MHRA) before they can be prescribed in the UK. Experts believe they may be available by late 2026, or early 2027.

What is the active ingredient in Wegovy? 

The active ingredient is semaglutide, a GLP-1 receptor agonist that mimics hormones involved in appetite control. 

Semaglutide, whether in tablets or an injectable pen, works by: 

  • reducing hunger signals in your brain 
  • slowing how quickly your stomach empties 
  • helping you feel fuller for longer 

Clinical weight loss on  Wegovy tablets

During the 2025 OASIS 4 trial looking at the effects of oral semaglutide on people with overweight or obesity, it was shown that patients on average lost 14% of their starting body weight while on Wegovy tablets.

This compares to the average weight loss of 21% seen on Wegovy injections.

However, overall weight loss varies depending on: 

  • your starting weight 
  • your diet
  • your level of physical activity
  • how well you stick to the treatment

Who is eligible for Wegovy tablets? 

As Wegovy tablets aren’t yet approved in the UK, we don’t know the eligibility criteria for the treatment. However, if they are approved, eligibility will be assessed by a qualified clinician to ensure safety and suitability.

What are the available doses of Wegovy tablets? 

In the US, the available doses of Wegovy tablets are as follows:

  • 1.5mg - starting dose
  • 4mg
  • 9mg
  • 25mg – maximum dose

As with Wegovy injections, patients are recommended to gradually increase their dose over time, so you can get use to the medication.

These doses may change in the UK once the treatment is approved by the MHRA.

How much does each dose cost? 

We currently don’t know how much Wegovy tablets will cost in the UK. The price of the treatment will depend on the price Novo Nordisk sets for the UK market, how available they are, and the dose you end up taking.

How to take Wegovy tablets

In the US, Wegovy tablets are approved to be taken once daily. The manufacturer states they need to be taken on an empty stomach after waking up, alongside a sip of water.

The manufacturere recommends that patients should then wait 30 minutes before eating, drinking, or taking any other oral medications.

What happens if you miss a dose? 

The manufacture states that if a dose of Wegovy tablets is missed, the dose should be skipped, and to resume the scheduled dose the next day.

Are there any common side effects of  Wegovy tablets? 

Common side effects noted in clinical trials included: 

  • nausea 
  • vomiting 
  • diarrhoea 
  • constipation 
  • headache 
  • fatigue 

When to seek urgent medical help 

The manufacturer currently advises patients to seek urgent advice if they experience: 

  • severe abdominal pain (possible pancreatitis) 
  • signs of an allergic reaction (swelling, difficulty breathing) 
  • persistent vomiting or dehydration 

Are Wegovy tablets the same as Rybelsus? 

No. Rybelsus is an oral semaglutide medication approved for type 2 diabetes, not specifically for weight loss. 

While both contain semaglutide, they have different uses in clinical trials, different maximum doses, and Wegovy is not currently licensed in the UK.

Frequently asked questions about Wegovy  tablets

Are Wegovy tablets available in the UK? 

Wegovy tablets are not yet available in the UK. They first need to be approved by the MHRA.

Do Wegovy tablets work without diet changes? 

In clinical trials, Wegovy tablets worked best when combined with lifestyle changes. Treatment can help reduce appetite, but long-term success comes from sustainable habits. 

How quickly do they work? 

Clinical trials data showed that some people notice reduced appetite within weeks of starting Wegovy tablets, but meaningful weight loss typically developed over several months. 

Summary of Wegovy  tablets 

“If Wegovy tablets (semaglutide tablets) become available in the UK, they could offer a potential needle-free approach to weight loss, helping patients manage their appetites and support healthier habits.”

“However, to ensure the treatment is safe and suitable for the UK market, it first needs to be approved by the MHRA.”

Ayesha Bashir, weight loss expert at myBMI

Sources  

How it works

Here's how our service works in 3 simple steps:

Alt text
  • Online Consultation

    Start by completing a quick online consultation. This helps our clinicians understand your health and decide whether treatment is safe and suitable for you. As part of this, you’ll be asked to submit photos to confirm your identity and your weight. These will only ever be viewed by your clinician.

  • Clinical Review

    After your consultation, one of our clinicians will carefully assess whether treatment is right for you. If approved, they’ll issue a prescription and your medication will be delivered straight to your door with our discreet, tracked, and signed-for service.

  • Ongoing Care

    Your journey doesn’t stop with your delivery. Our clinicians are here to support you every step of the way. You can check in anytime through your account for advice, and we’ll review your progress regularly to help you stay on track and achieve lasting results. You’ll also be invited to join our exclusive support group, giving you access to expert medical guidance and tailored content designed to keep you motivated.